Showing 1 - 10 of 8,166
This report examines examples of new and emerging governance models that aim to support the responsible development of diagnostics and treatments based on the latest advances in biomedicine. In particular, it presents programmes and initiatives that aim to manage uncertainty in the development...
Persistent link: https://www.econbiz.de/10011632331
This paper analyzes the technology commercialization strategy of an innovating firm when the incumbent firms possess specialized commercialization capabilities. According to the predominant framework, if the innovation is protected by a strong appropriabilty regime the optimal strategy is to...
Persistent link: https://www.econbiz.de/10010357556
, biotechnology, and biomaterials, subfields were built through a keyword-driven approach to capture the bioeconomy. We conducted a …
Persistent link: https://www.econbiz.de/10013387801
Persistent link: https://www.econbiz.de/10003388921
We analyse the determinants of network formation in Germany’s biotechnology industry using social network analysis … biotechnology network. -- Biotechnology ; network formation ; degree centrality ; R&D policy … Determinanten auf regionale und interregionale Netzwerke in der deutschen Biotechnologie. Dabei wird zunächst auf Basis von …
Persistent link: https://www.econbiz.de/10009669599
of commercial biotechnology in Germany. The current paper tries to fill this gap. We find that although these contests …
Persistent link: https://www.econbiz.de/10003761389
The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make … particular not discriminating different kinds of ‘risk’ in the field of biotechnology. The study combines survey data of German …
Persistent link: https://www.econbiz.de/10003178532
Persistent link: https://www.econbiz.de/10001570750
Persistent link: https://www.econbiz.de/10013266352